Vaxcyte, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2020 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Vaxcyte, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2020 to Q3 2024.
  • Vaxcyte, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 1, 2024 was 125M shares, a 31% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 125M +29.5M +31% Nov 1, 2024 10-Q 2024-11-05
Q2 2024 112M +17.8M +18.9% Aug 2, 2024 10-Q 2024-08-06
Q1 2024 109M +15.1M +16.1% May 6, 2024 10-Q 2024-05-08
Q3 2023 95.2M +16.2M +20.5% Nov 2, 2023 10-Q 2023-11-06
Q2 2023 93.8M +34.5M +58.2% Aug 3, 2023 10-Q 2023-08-08
Q1 2023 93.7M +35.4M +60.7% May 4, 2023 10-Q 2023-05-08
Q3 2022 79M +26.2M +49.6% Nov 3, 2022 10-Q 2022-11-07
Q2 2022 59.3M +7.13M +13.7% Aug 4, 2022 10-Q 2022-08-08
Q1 2022 58.3M +6.99M +13.6% May 5, 2022 10-Q 2022-05-09
Q3 2021 52.8M +1.84M +3.6% Nov 8, 2021 10-Q 2021-11-10
Q2 2021 52.2M +1.27M +2.49% Aug 9, 2021 10-Q 2021-08-11
Q1 2021 51.3M Mar 25, 2021 10-K 2021-03-29
Q3 2020 50.9M Nov 11, 2020 10-Q 2020-11-12
Q2 2020 50.9M Aug 11, 2020 10-Q 2020-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.